Douglas Godbold

Array ( [id] => 10443208 [patent_doc_number] => 20150328220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-19 [patent_title] => 'METHODS OF TREATING CHRONIC KIDNEY DISEASE CHARACTERIZED BY MACROALBUMINURIA' [patent_app_type] => utility [patent_app_number] => 14/711922 [patent_app_country] => US [patent_app_date] => 2015-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11206 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14711922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10347470 [patent_doc_number] => 20150232475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 14/695460 [patent_app_country] => US [patent_app_date] => 2015-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14463 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14695460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10324345 [patent_doc_number] => 20150209349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-30 [patent_title] => 'Piperazine Compounds' [patent_app_type] => utility [patent_app_number] => 14/683913 [patent_app_country] => US [patent_app_date] => 2015-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65670 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14683913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10373073 [patent_doc_number] => 20150258080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-17 [patent_title] => 'THERAPEUTIC COMBINATIONS WITH ESTROGEN RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 14/645585 [patent_app_country] => US [patent_app_date] => 2015-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 33341 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14645585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10289139 [patent_doc_number] => 20150174137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'COMPOSITIONS FOR TREATING MICROBIAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 14/632547 [patent_app_country] => US [patent_app_date] => 2015-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4601 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14632547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10281566 [patent_doc_number] => 20150166563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'CYCLIC BRIDGEHEAD ETHER DGAT1 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/628205 [patent_app_country] => US [patent_app_date] => 2015-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34139 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14628205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10346145 [patent_doc_number] => 20150231151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 14/626086 [patent_app_country] => US [patent_app_date] => 2015-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8059 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14626086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10265868 [patent_doc_number] => 20150150864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-04 [patent_title] => 'SUBSTITUTED (E)-N\'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/623370 [patent_app_country] => US [patent_app_date] => 2015-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41432 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14623370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10365792 [patent_doc_number] => 20150250798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'Methods and Pharmaceutical Compositions For Treating Down Syndrome' [patent_app_type] => utility [patent_app_number] => 14/613601 [patent_app_country] => US [patent_app_date] => 2015-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13074 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14613601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10412528 [patent_doc_number] => 20150297537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => 'Compositions for the Treatment of CNS-Related Conditions' [patent_app_type] => utility [patent_app_number] => 14/613220 [patent_app_country] => US [patent_app_date] => 2015-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14899 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14613220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10263391 [patent_doc_number] => 20150148388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-28 [patent_title] => 'CHEMICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 14/608297 [patent_app_country] => US [patent_app_date] => 2015-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14855 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14608297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10263427 [patent_doc_number] => 20150148424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-28 [patent_title] => 'STABLE DOSAGE FORMS OF LEVOMILNACIPRAN' [patent_app_type] => utility [patent_app_number] => 14/607482 [patent_app_country] => US [patent_app_date] => 2015-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17665 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14607482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10311501 [patent_doc_number] => 20150196502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-16 [patent_title] => 'FORMULATIONS, SALTS AND POLYMORPHS OF TRANSNORSERTRALINE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/605334 [patent_app_country] => US [patent_app_date] => 2015-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 36117 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14605334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10248503 [patent_doc_number] => 20150133499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-14 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS OF 5-HYDROXYTRYPTOPHAN AND SEROTONIN-ENHANCING COMPOUND' [patent_app_type] => utility [patent_app_number] => 14/605313 [patent_app_country] => US [patent_app_date] => 2015-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5357 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14605313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11721128 [patent_doc_number] => 09693973 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-04 [patent_title] => 'Active substance combination of licochalcone A and phenoxyethanol' [patent_app_type] => utility [patent_app_number] => 14/604949 [patent_app_country] => US [patent_app_date] => 2015-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14340 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14604949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10263543 [patent_doc_number] => 20150148541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-28 [patent_title] => 'NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 14/601194 [patent_app_country] => US [patent_app_date] => 2015-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19579 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14601194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10241506 [patent_doc_number] => 20150126501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-07 [patent_title] => 'Fused Ring Compound For Use As Mineralocorticoid Receptor Antagonist' [patent_app_type] => utility [patent_app_number] => 14/591081 [patent_app_country] => US [patent_app_date] => 2015-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20376 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14591081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10367015 [patent_doc_number] => 20150252020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'Intramolecular Hydrogen-Bonded Nitric Oxide Synthase Inhibitors' [patent_app_type] => utility [patent_app_number] => 14/589690 [patent_app_country] => US [patent_app_date] => 2015-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7128 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11270454 [patent_doc_number] => 20160333002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-17 [patent_title] => 'N, N\' SUBSTITUTED PIPERIDINAMINE COMPOUNDS, AND PREPARATION METHOD AND USAGE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/105702 [patent_app_country] => US [patent_app_date] => 2014-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 31593 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11121954 [patent_doc_number] => 20160318929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'PYRAZOLO[1,5-A]PYRIDINE DERIVATIVES AND METHODS OF THEIR USE' [patent_app_type] => utility [patent_app_number] => 15/108400 [patent_app_country] => US [patent_app_date] => 2014-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48291 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108400 [rel_patent_id] =>[rel_patent_doc_number] =>)